Clinical evidence deficiencies drive CHMP negative opinions and pre-opinion withdrawals in the EU centralized procedure (2021–2025)
IntroductionMarket authorization applications that do not obtain authorization after CHMP review, whether through a formal negative opinion or pre-opinion withdrawal, remain poorly characterized at a systems level, despite substantial strategic, and commercial implications for applicants, and the br...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Frontiers Media S.A.
2026-07-01
|
| Rangatū: | Frontiers in Medicine |
| Ngā marau: | |
| Urunga tuihono: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1875064/full |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|